Insider · CIK 0001903669
Javier B. Szwarcberg
Files at SPRB (SPRUCE BIOSCIENCES, INC.). First filing -, latest -.
In brief
Javier B. Szwarcberg files SEC Form 4 as CEO and director at SPRB (SPRUCE BIOSCIENCES, INC.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Javier B. Szwarcberg has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 37 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 30, 2026 | SPRB SPRUCE BIOSCIENCES, INC. | AGrant or award Common Stock | +266 | $4.53 | $1,205 | 19,270 | Jul 9, 2026 |
| Dec 31, 2025 | SPRB SPRUCE BIOSCIENCES, INC. | AGrant or award Common Stock | +4,690 | $4.53 | $21k | 19,004 | Jan 5, 2026 |
| Dec 15, 2025 | SPRB SPRUCE BIOSCIENCES, INC. | MOption exercise Common Stock | +1,480 | $0.00 | $0 | 14,478 | Dec 17, 2025 |
| Dec 15, 2025 | SPRB SPRUCE BIOSCIENCES, INC. | FTax withholding Common Stock | -752 | $80.67 | $61k | 13,726 | Dec 17, 2025 |
| Dec 15, 2025 | SPRB SPRUCE BIOSCIENCES, INC. | MOption exercise Common Stock | +1,196 | $0.00 | $0 | 14,922 | Dec 17, 2025 |
| Dec 15, 2025 | SPRB SPRUCE BIOSCIENCES, INC. | FTax withholding Common Stock | -608 | $80.67 | $49k | 14,314 | Dec 17, 2025 |
| Dec 11, 2025 | SPRB SPRUCE BIOSCIENCES, INC. | AGrant or award Employee Stock Option (right to buy)derivative | +1,666 | - | - | 1,666 | Dec 17, 2025 |
| Dec 11, 2025 | SPRB SPRUCE BIOSCIENCES, INC. | DDisposition to issuer Employee Stock Option (right to buy)derivative | -1,666 | - | - | 0 | Dec 17, 2025 |
| Dec 15, 2025 | SPRB SPRUCE BIOSCIENCES, INC. | MOption exercise Restricted Stock Unitsderivative | -1,480 | $0.00 | $0 | 1,480 | Dec 17, 2025 |
| Dec 15, 2025 | SPRB SPRUCE BIOSCIENCES, INC. | MOption exercise Restricted Stock Unitsderivative | -1,196 | $0.00 | $0 | 2,392 | Dec 17, 2025 |
| Dec 11, 2025 | SPRB SPRUCE BIOSCIENCES, INC. | AGrant or award Employee Stock Option (right to buy)derivative | +10,000 | - | - | 10,000 | Dec 15, 2025 |
| Dec 11, 2025 | SPRB SPRUCE BIOSCIENCES, INC. | DDisposition to issuer Employee Stock Option (right to buy)derivative | -10,000 | - | - | 0 | Dec 15, 2025 |
| Dec 10, 2025 | SPRB SPRUCE BIOSCIENCES, INC. | MOption exercise Common Stock | +1,196 | $0.00 | $0 | 10,670 | Dec 12, 2025 |
| Dec 10, 2025 | SPRB SPRUCE BIOSCIENCES, INC. | FTax withholding Common Stock | -428 | $85.67 | $37k | 10,242 | Dec 12, 2025 |
| Dec 11, 2025 | SPRB SPRUCE BIOSCIENCES, INC. | MOption exercise Common Stock | +4,950 | $0.00 | $0 | 15,192 | Dec 12, 2025 |
| Dec 11, 2025 | SPRB SPRUCE BIOSCIENCES, INC. | FTax withholding Common Stock | -2,194 | $88.41 | $194k | 12,998 | Dec 12, 2025 |
| Dec 10, 2025 | SPRB SPRUCE BIOSCIENCES, INC. | MOption exercise Restricted Stock Unitsderivative | -1,196 | $0.00 | $0 | 3,588 | Dec 12, 2025 |
| Dec 11, 2025 | SPRB SPRUCE BIOSCIENCES, INC. | AGrant or award Restricted Stock Unitsderivative | +19,800 | $0.00 | $0 | 19,800 | Dec 12, 2025 |
| Dec 11, 2025 | SPRB SPRUCE BIOSCIENCES, INC. | MOption exercise Restricted Stock Unitsderivative | -4,950 | $0.00 | $0 | 14,850 | Dec 12, 2025 |
| Oct 20, 2025 | SPRB SPRUCE BIOSCIENCES, INC. | MOption exercise Common Stock | +4,784 | $0.00 | $0 | 11,013 | Oct 22, 2025 |
| Oct 20, 2025 | SPRB SPRUCE BIOSCIENCES, INC. | FTax withholding Common Stock | -1,539 | $148.16 | $228k | 9,474 | Oct 22, 2025 |
| Oct 20, 2025 | SPRB SPRUCE BIOSCIENCES, INC. | AGrant or award Restricted Stock Unitsderivative | +4,784 | $0.00 | $0 | 4,784 | Oct 22, 2025 |
| Oct 20, 2025 | SPRB SPRUCE BIOSCIENCES, INC. | MOption exercise Restricted Stock Unitsderivative | -4,784 | $0.00 | $0 | 0 | Oct 22, 2025 |
| Dec 10, 2024 | SPRB SPRUCE BIOSCIENCES, INC. | MOption exercise Common Stock | +358,800 | $0.00 | $0 | 466,121 | Dec 20, 2024 |
| Dec 10, 2024 | SPRB SPRUCE BIOSCIENCES, INC. | FTax withholding Common Stock | -128,020 | $0.54 | $69k | 338,101 | Dec 20, 2024 |
| Dec 16, 2024 | SPRB SPRUCE BIOSCIENCES, INC. | MOption exercise Common Stock | +89,700 | $0.00 | $0 | 427,801 | Dec 20, 2024 |
| Dec 16, 2024 | SPRB SPRUCE BIOSCIENCES, INC. | FTax withholding Common Stock | -32,005 | $0.39 | $12k | 395,796 | Dec 20, 2024 |
| Dec 16, 2024 | SPRB SPRUCE BIOSCIENCES, INC. | MOption exercise Common Stock | +111,000 | $0.00 | $0 | 506,796 | Dec 20, 2024 |
| Dec 16, 2024 | SPRB SPRUCE BIOSCIENCES, INC. | FTax withholding Common Stock | -39,605 | $0.39 | $15k | 467,191 | Dec 20, 2024 |
| Dec 10, 2024 | SPRB SPRUCE BIOSCIENCES, INC. | MOption exercise Restricted Stock Unitsderivative | -358,800 | $0.00 | $0 | 358,800 | Dec 20, 2024 |
| Dec 16, 2024 | SPRB SPRUCE BIOSCIENCES, INC. | MOption exercise Restricted Stock Unitsderivative | -89,700 | $0.00 | $0 | 269,100 | Dec 20, 2024 |
| Dec 16, 2024 | SPRB SPRUCE BIOSCIENCES, INC. | MOption exercise Restricted Stock Unitsderivative | -111,000 | $0.00 | $0 | 222,000 | Dec 20, 2024 |
| Dec 15, 2023 | SPRB SPRUCE BIOSCIENCES, INC. | MOption exercise Common Stock | +111,000 | $0.00 | $0 | 145,705 | Dec 18, 2023 |
| Dec 15, 2023 | SPRB SPRUCE BIOSCIENCES, INC. | FTax withholding Common Stock | -38,384 | $1.66 | $64k | 107,321 | Dec 18, 2023 |
| Dec 14, 2023 | SPRB SPRUCE BIOSCIENCES, INC. | AGrant or award Restricted Stock Unitsderivative | +717,600 | $0.00 | $0 | 717,600 | Dec 18, 2023 |
| Dec 15, 2023 | SPRB SPRUCE BIOSCIENCES, INC. | MOption exercise Restricted Stock Unitsderivative | -111,000 | $0.00 | $0 | 333,000 | Dec 18, 2023 |
| Nov 26, 2023 | SPRB SPRUCE BIOSCIENCES, INC. | AGrant or award Employee Stock Option (right to buy)derivative | +125,000 | $0.00 | $0 | 125,000 | Nov 28, 2023 |
Questions about Javier B. Szwarcberg
Answered from the filings on this page, as of the latest one.
Is Javier B. Szwarcberg buying or selling?
Javier B. Szwarcberg has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Javier B. Szwarcberg's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Javier B. Szwarcberg has 0.
Where does Javier B. Szwarcberg file Form 4?
Javier B. Szwarcberg has filed Form 4 at SPRB (SPRUCE BIOSCIENCES, INC.) as Chief Executive Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.